IntegenX

company

About

IntegenX designs, manufactures and markets automation systems facilitating reliable micro sample preparation and analysis.

  • 101 - 250

Details

Last Funding Type
Debt Financing
Last Funding Money Raised
$10M
Industries
Biotechnology,Health Diagnostics
Founded date
Jan 1, 2006
Number Of Employee
101 - 250
Operating Status
Active

IntegenX, Inc. designs, manufactures, and markets automation systems that enable reliable microsample preparation and analysis for the life sciences. It offers Apollo 100, a platform that allows the processing of DNA sequencing reactions; Apollo 200, an integrated sample preparation system for human DNA identification; microfluidics for DNA sequencing, molecular diagnostics, and human identification applications; and Apollo 324 system, a benchtop robotic workstation that automates the construction of DNA fragment libraries for next-generation sequencing. The company was formerly known as Microchip Biotechnologies, Inc. and changed its name to IntegenX, Inc. in March 2010. The company was incorporated in 2003 and is based in Pleasanton, California.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$72.60M
IntegenX has raised a total of $72.60M in funding over 2 rounds. Their latest funding was raised on Sep 22, 2014 from a Debt Financing round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 22, 2014 Debt Financing $10M 1 Detail
Dec 13, 2011 Series C $40M 1 Detail
Nov 12, 2009 Series B $18.10M 1 Detail
Aug 29, 2006 Series A $4.50M 1 Detail

Investors

Number of Lead Investors
Number of Investors
2
IntegenX is funded by 2 investors. Horizon Technology Finance and Rona Syndicates are the most recent investors.
Investor Name Lead Investor Funding Round
Horizon Technology Finance Debt Financing
Rona Syndicates Series C